Brain Mapping Instruments Market By Product Type (Computed Tomography, Positron Emission Tomography (PET), Electroencephalography (EEG), Near-Infrared Spectroscopy (NIRS), Magnetic Resonance Imaging (MRI), Others), By End User (Hospitals, Ambulatory Centers, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031

Brain Mapping Instruments Market

The brain map is a revolutionary new tool in accurately identifying the problem areas of the brain. It takes the guesswork out of the assessment process and provides an accurate road map for improving the patient's health and well-being. Brain mapping is often critical to the success of epilepsy and brain tumor surgeries. Mapping the cerebral cortex can be performed either extra-operatively or intraoperatively.

Key factors driving the growth of the brain mapping instruments market include the rise in the prevalence of target diseases like dementia, epilepsy, Parkinsonism, Huntington's, multiple sclerosis (MS), brain stroke, and cerebral palsy (CP), the surge in geriatric population and growing adoption of brain mapping instruments to facilitate faster diagnosis of chronic diseases. Moreover, increasing incidence of chronic diseases, rise in demand for health care services and continuous developments in the field of brain mapping are expected to notably contribute toward the market growth. Furthermore, the global brain mapping instruments market growth is largely driven by factors such as an increase in advancements of medical technology which is expected to surely lead to the growth of the market. Prominent players in the global brain mapping instruments market have opted for various strategies such as product launch, acquisitions, and investments in R&D for advancement in brain mapping instruments to strengthen their position in the market and sustain the competitive environment. A significant increase in awareness about the advantages of brain mapping instruments and an increase in the usage of brain mapping instruments in the diagnosis of the brain injuries and a rise in the number of patients suffering from brain diseases are some of the key factors driving the growth of the market.

However, high costs associated with the brain mapping process and poor health insurance coverage hamper restrict the market growth. Conversely, the increase in the adoption of brain mapping instruments in healthcare organizations has changed the market dynamics in the forecast period and is expected to provide lucrative opportunities for the growth of the market. Extensive R&D activities in the field of brain mapping instruments along with significant improvements in medical devices are anticipated to open new avenues for the expansion of the market.

The brain mapping instruments market is segmented based on product type, end user and region. On the basis of product type, the market is classified into computed tomography (CT), positron emission tomography (PET), electroencephalography (EEG), near-infrared spectroscopy (NIRS), magnetic resonance imaging (MRI) and others. On the basis of end user, the market is classified into hospitals, clinics, ambulatory centers and others. Region wise, the market is studied across North America (the U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and Rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA). 

The key players profiled in the study include Elekta AB, Siemens AG, Koninklijke Philips N.V., Medtronic plc, Medtronic plc, General Electric Company, Advanced Brain Monitoring, Inc., Brain Products GmbH, Brainscope Company Inc., and Compumedics Limited. The players in the market have been actively engaged in the adoption various strategies such as acquisition, product launch, partnership, product approval and product development to remain competitive and gain an advantage over the competitors in the market. For instance, in October 2022, Elekta's new Leksell Gamma Knife radiosurgery platform received FDA (Food and Drug Administration) 510(k) clearance. Clearance of Leksell Gamma Knife will help the company to gain a strong foothold in the brain mapping instruments market.                                                                                                                                        

Key Market Insights

By product type, the computed tomography segment was the highest revenue contributor to the market and is estimated to continue this during the analysis period, with a CAGR of 5.5%. However, the positron emission tomography (PET) segment is estimated to be the fastest-growing segment with a CAGR of 7.2% during the forecast period.

By end user, the hospitals segment was the highest revenue contributor to the market and is estimated to continue this during the analysis period, with a CAGR of 6.0%. Moreover, the ambulatory centers segment is estimated to be the fastest-growing segment with a CAGR of 6.5% during the forecast period.

Based on region, North America garnered the largest revenue share in 2021, whereas Asia-Pacific is anticipated to grow at the highest CAGR of 7.4% during the forecast period.

Overview

The brain mapping instruments market was valued at $2.1 billion in 2021, and is estimated to reach $3.7 billion by 2031, growing at a CAGR of 6.1% from 2022 to 2031.  

The brain is a highly complex organ made up of billions of cells called neurons. Brain mapping is a set of neuroscience techniques predicated on the mapping of (biological) quantities or properties onto spatial representations of the brain resulting in maps. The brain map is also called a neuro map which can evaluate the brainwaves and identify opportunities to improve communication between various regions of the brain. The brain map is able to capture a window of brain activity, analyze the data, and create a visual representation for each lobe of the brain and each specific brain wave like delta, theta, alpha and beta. It works through a physical process of collecting data. Although, there are various methods for collecting data to produce a visual brain map, all of them include a same noninvasive, or invasive, physical connection to the head or scalp of the patient to detect and collect the brainwave data. The data collected is only considered a short-term window of brain activity but can indicate types of brain activity regarding the types of brain waves, their location in the brain. 

The growth of the brain mapping instruments market is driven by surge in incidences of brain diseases in different parts of the world, improvement in the healthcare infrastructure, rise in health concerns, and increase in adoption of technology that help to increase the demand for brain mapping instruments. Moreover, large medical technology firms all over the world are increasingly focusing on acquiring companies that provide solutions for brain mapping instruments, which is expected to notably contribute toward the market growth. Furthermore, the global brain mapping instruments market growth is largely driven by factors such as increase in awareness regarding the neurological conditions and rise in government initiatives regarding advanced healthcare systems which is expected to lead to the growth of the market. Prominent players in the global brain mapping instruments market have opted various strategies such as product launches, acquisition, and investments in R&D for advancement in brain mapping instruments to strengthen their position in the market and sustain the competitive environment.  

A significant increase in awareness about the advantages of brain mapping instruments and technological advancements in devices, and surge in number of accidents and trauma are some of the key factors driving the growth of the market. For instance, in September 2020, AngioDynamics, Inc. announced the launch of the Auryon Atherectomy System, a newly developed innovative technology for the treatment of Peripheral Artery Disease (PAD), including Critical Limb Ischemia (CLI) and In-Stent Restenosis (ISR). However, the high cost and greater maintenance associated with these devices and lack of skilled professionals restrict market growth. Conversely, increased government initiatives to support patients with neurological conditions is expected to provide lucrative opportunities for the growth of the market in the near future. Extensive R&D activities in the field of brain mapping along with significant improvement in medical infrastructure are anticipated to open new avenues for the expansion of the market. 

The brain mapping instruments market is segmented based on products type, end user and region. On the basis of products type, the market is classified into computed tomography (CT), positron emission tomography (PET), electroencephalography (EEG), Near-infrared spectroscopy (NIRS), magnetic resonance imaging (MRI) and others. On the basis of end user, the market is divided into hospitals, clinics, ambulatory centers and others. Region wise, the market is studied across North America (the U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and Rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA). 

Major companies profiled in the report include Elekta AB, GE Company, Siemens AG, Medtronic plc, Brain Products GmbH, Compumedics Limited, Koninklijke Philips N.V., Brainscope Company Inc., Nihon Kohden Corporation, and Advanced Brain Monitoring, Inc. 

Key Benefits For Stakeholders

●This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the brain mapping instruments market analysis from 2021 to 2031 to identify the prevailing brain mapping instruments market opportunities.

●The market research is offered along with information related to key drivers, restraints, and opportunities.

●Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.

●In-depth analysis of the brain mapping instruments market segmentation assists to determine the prevailing market opportunities.

●Major countries in each region are mapped according to their revenue contribution to the global market.

●Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.

●The report includes the analysis of the regional as well as global brain mapping instruments market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

○ General Electric Compan

Scope of Brain Mapping Instruments Market Report

1.1. Report description

1.2. Key market segments

1.3. Key benefits to the stakeholders

1.4. Research Methodology

1.4.1. Primary research

1.4.2. Secondary research

1.4.3. Analyst tools and models

2.1. CXO Perspective

3.1. Market definition and scope

3.2. Key findings

3.2.1. Top impacting factors

3.2.2. Top investment pockets

3.3. Porter’s five forces analysis

3.3.1. Bargaining power of suppliers

3.3.2. Bargaining power of buyers

3.3.3. Threat of substitutes

3.3.4. Threat of new entrants

3.3.5. Intensity of rivalry

3.4. Market dynamics

3.4.1. Drivers

3.4.1.1. Increase in the prevalence of brain diseases

3.4.1.2. Technological advancements in the brain mapping instruments

3.4.1.3. Surge in the geriatric population

3.4.2. Restraints

3.4.2.1. High cost of brain mapping instruments and therapy

3.4.3. Opportunities

3.4.3.1. Surge in the research-based activities for brain issues

3.5. COVID-19 Impact Analysis on the market

4.1. Overview

4.1.1. Market size and forecast

4.2. Computed Tomography

4.2.1. Key market trends, growth factors and opportunities

4.2.2. Market size and forecast, by region

4.2.3. Market share analysis by country

4.3. Positron Emission Tomography (PET)

4.3.1. Key market trends, growth factors and opportunities

4.3.2. Market size and forecast, by region

4.3.3. Market share analysis by country

4.4. Electroencephalography (EEG)

4.4.1. Key market trends, growth factors and opportunities

4.4.2. Market size and forecast, by region

4.4.3. Market share analysis by country

4.5. Near-Infrared Spectroscopy (NIRS)

4.5.1. Key market trends, growth factors and opportunities

4.5.2. Market size and forecast, by region

4.5.3. Market share analysis by country

4.6. Magnetic Resonance Imaging (MRI)

4.6.1. Key market trends, growth factors and opportunities

4.6.2. Market size and forecast, by region

4.6.3. Market share analysis by country

4.7. Others

4.7.1. Key market trends, growth factors and opportunities

4.7.2. Market size and forecast, by region

4.7.3. Market share analysis by country

5.1. Overview

5.1.1. Market size and forecast

5.2. Hospitals

5.2.1. Key market trends, growth factors and opportunities

5.2.2. Market size and forecast, by region

5.2.3. Market share analysis by country

5.3. Ambulatory Centers

5.3.1. Key market trends, growth factors and opportunities

5.3.2. Market size and forecast, by region

5.3.3. Market share analysis by country

5.4. Others

5.4.1. Key market trends, growth factors and opportunities

5.4.2. Market size and forecast, by region

5.4.3. Market share analysis by country

6.1. Overview

6.1.1. Market size and forecast By Region

6.2. North America

6.2.1. Key trends and opportunities

6.2.2. Market size and forecast, by Product Type

6.2.3. Market size and forecast, by End User

6.2.4. Market size and forecast, by country

6.2.4.1. U.S.

6.2.4.1.1. Key market trends, growth factors and opportunities

6.2.4.1.2. Market size and forecast, by Product Type

6.2.4.1.3. Market size and forecast, by End User

6.2.4.2. Canada

6.2.4.2.1. Key market trends, growth factors and opportunities

6.2.4.2.2. Market size and forecast, by Product Type

6.2.4.2.3. Market size and forecast, by End User

6.2.4.3. Mexico

6.2.4.3.1. Key market trends, growth factors and opportunities

6.2.4.3.2. Market size and forecast, by Product Type

6.2.4.3.3. Market size and forecast, by End User

6.3. Europe

6.3.1. Key trends and opportunities

6.3.2. Market size and forecast, by Product Type

6.3.3. Market size and forecast, by End User

6.3.4. Market size and forecast, by country

6.3.4.1. Germany

6.3.4.1.1. Key market trends, growth factors and opportunities

6.3.4.1.2. Market size and forecast, by Product Type

6.3.4.1.3. Market size and forecast, by End User

6.3.4.2. France

6.3.4.2.1. Key market trends, growth factors and opportunities

6.3.4.2.2. Market size and forecast, by Product Type

6.3.4.2.3. Market size and forecast, by End User

6.3.4.3. UK

6.3.4.3.1. Key market trends, growth factors and opportunities

6.3.4.3.2. Market size and forecast, by Product Type

6.3.4.3.3. Market size and forecast, by End User

6.3.4.4. Italy

6.3.4.4.1. Key market trends, growth factors and opportunities

6.3.4.4.2. Market size and forecast, by Product Type

6.3.4.4.3. Market size and forecast, by End User

6.3.4.5. Spain

6.3.4.5.1. Key market trends, growth factors and opportunities

6.3.4.5.2. Market size and forecast, by Product Type

6.3.4.5.3. Market size and forecast, by End User

6.3.4.6. Rest of Europe

6.3.4.6.1. Key market trends, growth factors and opportunities

6.3.4.6.2. Market size and forecast, by Product Type

6.3.4.6.3. Market size and forecast, by End User

6.4. Asia-Pacific

6.4.1. Key trends and opportunities

6.4.2. Market size and forecast, by Product Type

6.4.3. Market size and forecast, by End User

6.4.4. Market size and forecast, by country

6.4.4.1. China

6.4.4.1.1. Key market trends, growth factors and opportunities

6.4.4.1.2. Market size and forecast, by Product Type

6.4.4.1.3. Market size and forecast, by End User

6.4.4.2. Japan

6.4.4.2.1. Key market trends, growth factors and opportunities

6.4.4.2.2. Market size and forecast, by Product Type

6.4.4.2.3. Market size and forecast, by End User

6.4.4.3. India

6.4.4.3.1. Key market trends, growth factors and opportunities

6.4.4.3.2. Market size and forecast, by Product Type

6.4.4.3.3. Market size and forecast, by End User

6.4.4.4. Australia

6.4.4.4.1. Key market trends, growth factors and opportunities

6.4.4.4.2. Market size and forecast, by Product Type

6.4.4.4.3. Market size and forecast, by End User

6.4.4.5. South Korea

6.4.4.5.1. Key market trends, growth factors and opportunities

6.4.4.5.2. Market size and forecast, by Product Type

6.4.4.5.3. Market size and forecast, by End User

6.4.4.6. Rest of Asia-Pacific

6.4.4.6.1. Key market trends, growth factors and opportunities

6.4.4.6.2. Market size and forecast, by Product Type

6.4.4.6.3. Market size and forecast, by End User

6.5. LAMEA

6.5.1. Key trends and opportunities

6.5.2. Market size and forecast, by Product Type

6.5.3. Market size and forecast, by End User

6.5.4. Market size and forecast, by country

6.5.4.1. Brazil

6.5.4.1.1. Key market trends, growth factors and opportunities

6.5.4.1.2. Market size and forecast, by Product Type

6.5.4.1.3. Market size and forecast, by End User

6.5.4.2. Saudi Arabia

6.5.4.2.1. Key market trends, growth factors and opportunities

6.5.4.2.2. Market size and forecast, by Product Type

6.5.4.2.3. Market size and forecast, by End User

6.5.4.3. South Africa

6.5.4.3.1. Key market trends, growth factors and opportunities

6.5.4.3.2. Market size and forecast, by Product Type

6.5.4.3.3. Market size and forecast, by End User

6.5.4.4. Rest of LAMEA

6.5.4.4.1. Key market trends, growth factors and opportunities

6.5.4.4.2. Market size and forecast, by Product Type

6.5.4.4.3. Market size and forecast, by End User

7.1. Introduction

7.2. Top winning strategies

7.3. Product Mapping of Top 10 Player

7.4. Competitive Dashboard

7.5. Competitive Heatmap

7.6. Top player positioning, 2021

8.1. Elekta AB

8.1.1. Company overview

8.1.2. Key Executives

8.1.3. Company snapshot

8.1.4. Operating business segments

8.1.5. Product portfolio

8.1.6. Business performance

8.1.7. Key strategic moves and developments

8.2. Siemens AG

8.2.1. Company overview

8.2.2. Key Executives

8.2.3. Company snapshot

8.2.4. Operating business segments

8.2.5. Product portfolio

8.2.6. Business performance

8.3. Koninklijke Philips N.V.

8.3.1. Company overview

8.3.2. Key Executives

8.3.3. Company snapshot

8.3.4. Operating business segments

8.3.5. Product portfolio

8.3.6. Business performance

8.3.7. Key strategic moves and developments

8.4. Medtronic plc

8.4.1. Company overview

8.4.2. Key Executives

8.4.3. Company snapshot

8.4.4. Operating business segments

8.4.5. Product portfolio

8.4.6. Business performance

8.5. Nihon Kohden Corporation

8.5.1. Company overview

8.5.2. Key Executives

8.5.3. Company snapshot

8.5.4. Operating business segments

8.5.5. Product portfolio

8.5.6. Business performance

8.6. Advanced Brain Monitoring, Inc.

8.6.1. Company overview

8.6.2. Key Executives

8.6.3. Company snapshot

8.6.4. Operating business segments

8.6.5. Product portfolio

8.7. General Electric Company

8.7.1. Company overview

8.7.2. Key Executives

8.7.3. Company snapshot

8.7.4. Operating business segments

8.7.5. Product portfolio

8.7.6. Business performance

8.8. Brainscope Company Inc.

8.8.1. Company overview

8.8.2. Key Executives

8.8.3. Company snapshot

8.8.4. Operating business segments

8.8.5. Product portfolio

8.9. Compumedics Limited

8.9.1. Company overview

8.9.2. Key Executives

8.9.3. Company snapshot

8.9.4. Operating business segments

8.9.5. Product portfolio

8.9.6. Business performance

8.9.7. Key strategic moves and developments

8.10. Brain Products GmbH

8.10.1. Company overview

8.10.2. Key Executives

8.10.3. Company snapshot

8.10.4. Operating business segments

8.10.5. Product portfoli

LIST OF TABLES

TABLE 01. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)

TABLE 02. BRAIN MAPPING INSTRUMENTS MARKET FOR COMPUTED TOMOGRAPHY, BY REGION, 2021-2031 ($MILLION)

TABLE 03. BRAIN MAPPING INSTRUMENTS MARKET FOR POSITRON EMISSION TOMOGRAPHY (PET), BY REGION, 2021-2031 ($MILLION)

TABLE 04. BRAIN MAPPING INSTRUMENTS MARKET FOR ELECTROENCEPHALOGRAPHY (EEG), BY REGION, 2021-2031 ($MILLION)

TABLE 05. BRAIN MAPPING INSTRUMENTS MARKET FOR NEAR-INFRARED SPECTROSCOPY (NIRS), BY REGION, 2021-2031 ($MILLION)

TABLE 06. BRAIN MAPPING INSTRUMENTS MARKET FOR MAGNETIC RESONANCE IMAGING (MRI), BY REGION, 2021-2031 ($MILLION)

TABLE 07. BRAIN MAPPING INSTRUMENTS MARKET FOR OTHERS, BY REGION, 2021-2031 ($MILLION)

TABLE 08. GLOBAL BRAIN MAPPING INSTRUMENTS MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 09. BRAIN MAPPING INSTRUMENTS MARKET FOR HOSPITALS, BY REGION, 2021-2031 ($MILLION)

TABLE 10. BRAIN MAPPING INSTRUMENTS MARKET FOR AMBULATORY CENTERS, BY REGION, 2021-2031 ($MILLION)

TABLE 11. BRAIN MAPPING INSTRUMENTS MARKET FOR OTHERS, BY REGION, 2021-2031 ($MILLION)

TABLE 12. BRAIN MAPPING INSTRUMENTS MARKET, BY REGION, 2021-2031 ($MILLION)

TABLE 13. NORTH AMERICA BRAIN MAPPING INSTRUMENTS MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)

TABLE 14. NORTH AMERICA BRAIN MAPPING INSTRUMENTS MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 15. NORTH AMERICA BRAIN MAPPING INSTRUMENTS MARKET, BY COUNTRY, 2021-2031 ($MILLION)

TABLE 16. U.S. BRAIN MAPPING INSTRUMENTS MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)

TABLE 17. U.S. BRAIN MAPPING INSTRUMENTS MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 18. CANADA BRAIN MAPPING INSTRUMENTS MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)

TABLE 19. CANADA BRAIN MAPPING INSTRUMENTS MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 20. MEXICO BRAIN MAPPING INSTRUMENTS MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)

TABLE 21. MEXICO BRAIN MAPPING INSTRUMENTS MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 22. EUROPE BRAIN MAPPING INSTRUMENTS MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)

TABLE 23. EUROPE BRAIN MAPPING INSTRUMENTS MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 24. EUROPE BRAIN MAPPING INSTRUMENTS MARKET, BY COUNTRY, 2021-2031 ($MILLION)

TABLE 25. GERMANY BRAIN MAPPING INSTRUMENTS MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)

TABLE 26. GERMANY BRAIN MAPPING INSTRUMENTS MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 27. FRANCE BRAIN MAPPING INSTRUMENTS MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)

TABLE 28. FRANCE BRAIN MAPPING INSTRUMENTS MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 29. UK BRAIN MAPPING INSTRUMENTS MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)

TABLE 30. UK BRAIN MAPPING INSTRUMENTS MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 31. ITALY BRAIN MAPPING INSTRUMENTS MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)

TABLE 32. ITALY BRAIN MAPPING INSTRUMENTS MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 33. SPAIN BRAIN MAPPING INSTRUMENTS MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)

TABLE 34. SPAIN BRAIN MAPPING INSTRUMENTS MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 35. REST OF EUROPE BRAIN MAPPING INSTRUMENTS MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)

TABLE 36. REST OF EUROPE BRAIN MAPPING INSTRUMENTS MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 37. ASIA-PACIFIC BRAIN MAPPING INSTRUMENTS MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)

TABLE 38. ASIA-PACIFIC BRAIN MAPPING INSTRUMENTS MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 39. ASIA-PACIFIC BRAIN MAPPING INSTRUMENTS MARKET, BY COUNTRY, 2021-2031 ($MILLION)

TABLE 40. CHINA BRAIN MAPPING INSTRUMENTS MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)

TABLE 41. CHINA BRAIN MAPPING INSTRUMENTS MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 42. JAPAN BRAIN MAPPING INSTRUMENTS MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)

TABLE 43. JAPAN BRAIN MAPPING INSTRUMENTS MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 44. INDIA BRAIN MAPPING INSTRUMENTS MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)

TABLE 45. INDIA BRAIN MAPPING INSTRUMENTS MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 46. AUSTRALIA BRAIN MAPPING INSTRUMENTS MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)

TABLE 47. AUSTRALIA BRAIN MAPPING INSTRUMENTS MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 48. SOUTH KOREA BRAIN MAPPING INSTRUMENTS MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)

TABLE 49. SOUTH KOREA BRAIN MAPPING INSTRUMENTS MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 50. REST OF ASIA-PACIFIC BRAIN MAPPING INSTRUMENTS MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)

TABLE 51. REST OF ASIA-PACIFIC BRAIN MAPPING INSTRUMENTS MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 52. LAMEA BRAIN MAPPING INSTRUMENTS MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)

TABLE 53. LAMEA BRAIN MAPPING INSTRUMENTS MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 54. LAMEA BRAIN MAPPING INSTRUMENTS MARKET, BY COUNTRY, 2021-2031 ($MILLION)

TABLE 55. BRAZIL BRAIN MAPPING INSTRUMENTS MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)

TABLE 56. BRAZIL BRAIN MAPPING INSTRUMENTS MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 57. SAUDI ARABIA BRAIN MAPPING INSTRUMENTS MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)

TABLE 58. SAUDI ARABIA BRAIN MAPPING INSTRUMENTS MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 59. SOUTH AFRICA BRAIN MAPPING INSTRUMENTS MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)

TABLE 60. SOUTH AFRICA BRAIN MAPPING INSTRUMENTS MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 61. REST OF LAMEA BRAIN MAPPING INSTRUMENTS MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)

TABLE 62. REST OF LAMEA BRAIN MAPPING INSTRUMENTS MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 63. ELEKTA AB: KEY EXECUTIVES

TABLE 64. ELEKTA AB: COMPANY SNAPSHOT

TABLE 65. ELEKTA AB: PRODUCT SEGMENTS

TABLE 66. ELEKTA AB: PRODUCT PORTFOLIO

TABLE 67. ELEKTA AB: KEY STRATERGIES

TABLE 68. SIEMENS AG: KEY EXECUTIVES

TABLE 69. SIEMENS AG: COMPANY SNAPSHOT

TABLE 70. SIEMENS AG: PRODUCT SEGMENTS

TABLE 71. SIEMENS AG: PRODUCT PORTFOLIO

TABLE 72. KONINKLIJKE PHILIPS N.V.: KEY EXECUTIVES

TABLE 73. KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT

TABLE 74. KONINKLIJKE PHILIPS N.V.: PRODUCT SEGMENTS

TABLE 75. KONINKLIJKE PHILIPS N.V.: PRODUCT PORTFOLIO

TABLE 76. KONINKLIJKE PHILIPS N.V.: KEY STRATERGIES

TABLE 77. MEDTRONIC PLC: KEY EXECUTIVES

TABLE 78. MEDTRONIC PLC: COMPANY SNAPSHOT

TABLE 79. MEDTRONIC PLC: PRODUCT SEGMENTS

TABLE 80. MEDTRONIC PLC: PRODUCT PORTFOLIO

TABLE 81. NIHON KOHDEN CORPORATION: KEY EXECUTIVES

TABLE 82. NIHON KOHDEN CORPORATION: COMPANY SNAPSHOT

TABLE 83. NIHON KOHDEN CORPORATION: PRODUCT SEGMENTS

TABLE 84. NIHON KOHDEN CORPORATION: PRODUCT PORTFOLIO

TABLE 85. ADVANCED BRAIN MONITORING, INC.: KEY EXECUTIVES

TABLE 86. ADVANCED BRAIN MONITORING, INC.: COMPANY SNAPSHOT

TABLE 87. ADVANCED BRAIN MONITORING, INC.: PRODUCT SEGMENTS

TABLE 88. ADVANCED BRAIN MONITORING, INC.: PRODUCT PORTFOLIO

TABLE 89. GENERAL ELECTRIC COMPANY: KEY EXECUTIVES

TABLE 90. GENERAL ELECTRIC COMPANY: COMPANY SNAPSHOT

TABLE 91. GENERAL ELECTRIC COMPANY: PRODUCT SEGMENTS

TABLE 92. GENERAL ELECTRIC COMPANY: PRODUCT PORTFOLIO

TABLE 93. BRAINSCOPE COMPANY INC.: KEY EXECUTIVES

TABLE 94. BRAINSCOPE COMPANY INC.: COMPANY SNAPSHOT

TABLE 95. BRAINSCOPE COMPANY INC.: PRODUCT SEGMENTS

TABLE 96. BRAINSCOPE COMPANY INC.: PRODUCT PORTFOLIO

TABLE 97. COMPUMEDICS LIMITED: KEY EXECUTIVES

TABLE 98. COMPUMEDICS LIMITED: COMPANY SNAPSHOT

TABLE 99. COMPUMEDICS LIMITED: PRODUCT SEGMENTS

TABLE 100. COMPUMEDICS LIMITED: PRODUCT PORTFOLIO

TABLE 101. COMPUMEDICS LIMITED: KEY STRATERGIES

TABLE 102. BRAIN PRODUCTS GMBH: KEY EXECUTIVES

TABLE 103. BRAIN PRODUCTS GMBH: COMPANY SNAPSHOT

TABLE 104. BRAIN PRODUCTS GMBH: PRODUCT SEGMENTS

TABLE 105. BRAIN PRODUCTS GMBH: PRODUCT PORTFOLIO LIST OF FIGURES

FIGURE 01. BRAIN MAPPING INSTRUMENTS MARKET, 2021-2031

FIGURE 02. SEGMENTATION OF BRAIN MAPPING INSTRUMENTS MARKET, 2021-2031

FIGURE 03. TOP INVESTMENT POCKETS IN BRAIN MAPPING INSTRUMENTS MARKET (2022-2031)

FIGURE 04. HIGH BARGAINING POWER OF SUPPLIERS

FIGURE 05. MODERATE BARGAINING POWER OF BUYERS

FIGURE 06. MODERATE THREAT OF SUBSTITUTES

FIGURE 07. MODERATE THREAT OF NEW ENTRANTS

FIGURE 08. MODERATE INTENSITY OF RIVALRY

FIGURE 09. DRIVERS, RESTRAINTS AND OPPORTUNITIES: GLOBALBRAIN MAPPING INSTRUMENTS MARKET

FIGURE 10. BRAIN MAPPING INSTRUMENTS MARKET, BY PRODUCT TYPE, 2021(%)

FIGURE 11. COMPARATIVE SHARE ANALYSIS OF BRAIN MAPPING INSTRUMENTS MARKET FOR COMPUTED TOMOGRAPHY, BY COUNTRY 2021 AND 2031(%)

FIGURE 12. COMPARATIVE SHARE ANALYSIS OF BRAIN MAPPING INSTRUMENTS MARKET FOR POSITRON EMISSION TOMOGRAPHY (PET), BY COUNTRY 2021 AND 2031(%)

FIGURE 13. COMPARATIVE SHARE ANALYSIS OF BRAIN MAPPING INSTRUMENTS MARKET FOR ELECTROENCEPHALOGRAPHY (EEG), BY COUNTRY 2021 AND 2031(%)

FIGURE 14. COMPARATIVE SHARE ANALYSIS OF BRAIN MAPPING INSTRUMENTS MARKET FOR NEAR-INFRARED SPECTROSCOPY (NIRS), BY COUNTRY 2021 AND 2031(%)

FIGURE 15. COMPARATIVE SHARE ANALYSIS OF BRAIN MAPPING INSTRUMENTS MARKET FOR MAGNETIC RESONANCE IMAGING (MRI), BY COUNTRY 2021 AND 2031(%)

FIGURE 16. COMPARATIVE SHARE ANALYSIS OF BRAIN MAPPING INSTRUMENTS MARKET FOR OTHERS, BY COUNTRY 2021 AND 2031(%)

FIGURE 17. BRAIN MAPPING INSTRUMENTS MARKET, BY END USER, 2021(%)

FIGURE 18. COMPARATIVE SHARE ANALYSIS OF BRAIN MAPPING INSTRUMENTS MARKET FOR HOSPITALS, BY COUNTRY 2021 AND 2031(%)

FIGURE 19. COMPARATIVE SHARE ANALYSIS OF BRAIN MAPPING INSTRUMENTS MARKET FOR AMBULATORY CENTERS, BY COUNTRY 2021 AND 2031(%)

FIGURE 20. COMPARATIVE SHARE ANALYSIS OF BRAIN MAPPING INSTRUMENTS MARKET FOR OTHERS, BY COUNTRY 2021 AND 2031(%)

FIGURE 21. BRAIN MAPPING INSTRUMENTS MARKET BY REGION, 2021

FIGURE 22. U.S. BRAIN MAPPING INSTRUMENTS MARKET, 2021-2031 ($MILLION)

FIGURE 23. CANADA BRAIN MAPPING INSTRUMENTS MARKET, 2021-2031 ($MILLION)

FIGURE 24. MEXICO BRAIN MAPPING INSTRUMENTS MARKET, 2021-2031 ($MILLION)

FIGURE 25. GERMANY BRAIN MAPPING INSTRUMENTS MARKET, 2021-2031 ($MILLION)

FIGURE 26. FRANCE BRAIN MAPPING INSTRUMENTS MARKET, 2021-2031 ($MILLION)

FIGURE 27. UK BRAIN MAPPING INSTRUMENTS MARKET, 2021-2031 ($MILLION)

FIGURE 28. ITALY BRAIN MAPPING INSTRUMENTS MARKET, 2021-2031 ($MILLION)

FIGURE 29. SPAIN BRAIN MAPPING INSTRUMENTS MARKET, 2021-2031 ($MILLION)

FIGURE 30. REST OF EUROPE BRAIN MAPPING INSTRUMENTS MARKET, 2021-2031 ($MILLION)

FIGURE 31. CHINA BRAIN MAPPING INSTRUMENTS MARKET, 2021-2031 ($MILLION)

FIGURE 32. JAPAN BRAIN MAPPING INSTRUMENTS MARKET, 2021-2031 ($MILLION)

FIGURE 33. INDIA BRAIN MAPPING INSTRUMENTS MARKET, 2021-2031 ($MILLION)

FIGURE 34. AUSTRALIA BRAIN MAPPING INSTRUMENTS MARKET, 2021-2031 ($MILLION)

FIGURE 35. SOUTH KOREA BRAIN MAPPING INSTRUMENTS MARKET, 2021-2031 ($MILLION)

FIGURE 36. REST OF ASIA-PACIFIC BRAIN MAPPING INSTRUMENTS MARKET, 2021-2031 ($MILLION)

FIGURE 37. BRAZIL BRAIN MAPPING INSTRUMENTS MARKET, 2021-2031 ($MILLION)

FIGURE 38. SAUDI ARABIA BRAIN MAPPING INSTRUMENTS MARKET, 2021-2031 ($MILLION)

FIGURE 39. SOUTH AFRICA BRAIN MAPPING INSTRUMENTS MARKET, 2021-2031 ($MILLION)

FIGURE 40. REST OF LAMEA BRAIN MAPPING INSTRUMENTS MARKET, 2021-2031 ($MILLION)

FIGURE 41. TOP WINNING STRATEGIES, BY YEAR

FIGURE 42. TOP WINNING STRATEGIES, BY DEVELOPMENT

FIGURE 43. TOP WINNING STRATEGIES, BY COMPANY

FIGURE 44. PRODUCT MAPPING OF TOP 10 PLAYERS

FIGURE 45. COMPETITIVE DASHBOARD

FIGURE 46. COMPETITIVE HEATMAP: BRAIN MAPPING INSTRUMENTS MARKET

FIGURE 47. TOP PLAYER POSITIONING, 2021

FIGURE 48. ELEKTA AB: NET REVENUE, 2019-2021 ($MILLION)

FIGURE 49. ELEKTA AB: REVENUE SHARE BY SEGMENT, 2021 (%)

FIGURE 50. ELEKTA AB: REVENUE SHARE BY REGION, 2021 (%)

FIGURE 51. SIEMENS: NET REVENUE, 2019-2021 ($MILLION)

FIGURE 52. SIEMENS: REVENUE SHARE BY SEGMENT, 2021 (%)

FIGURE 53. SIEMENS: REVENUE SHARE BY REGION, 2021 (%)

FIGURE 54. KONINKLIJKE PHILIPS N.V.: NET SALES, 2020-2022 ($MILLION)

FIGURE 55. KONINKLIJKE PHILIPS N.V.: REVENUE SHARE BY SEGMENT, 2022 (%)

FIGURE 56. KONINKLIJKE PHILIPS N.V.: REVENUE SHARE BY REGION, 2022 (%)

FIGURE 57. MEDTRONIC PLC: NET SALES, 2020-2022 ($MILLION)

FIGURE 58. MEDTRONIC PLC: REVENUE SHARE BY SEGMENT, 2022 (%)

FIGURE 59. MEDTRONIC PLC: REVENUE SHARE BY REGION, 2022 (%)

FIGURE 60. NIHON KOHDEN CORPORATION: NET SALES, 2019-2021 ($MILLION)

FIGURE 61. NIHON KOHDEN CORPORATION: REVENUE SHARE BY SEGMENT, 2021 (%)

FIGURE 62. NIHON KOHDEN CORPORATION: REVENUE SHARE BY REGION, 2021 (%)

FIGURE 63. GENERAL ELECTRIC COMPANY: NET REVENUE, 2020-2022 ($MILLION)

FIGURE 64. GENERAL ELECTRIC COMPANY: REVENUE SHARE BY SEGMENT, 2022 (%)

FIGURE 65. GENERAL ELECTRIC COMPANY: REVENUE SHARE BY REGION, 2022 (%)

FIGURE 66. COMPUMEDICS LIMITED: NET REVENUE, 2020-2022 ($MILLION)

FIGURE 67. COMPUMEDICS LIMITED: REVENUE SHARE BY REGION, 2022 (%